DAY 1 - Sunday, June 26, 2011
Welcome
Greetings from the American Diabetes Association’s 71st Scientific Sessions
The editorial staff of Medical Economics brings you daily
coverage of breaking news, the latest research findings, and reports of interest to the
readers of Medical Economics, Drug Topics, Formulary, and Contemporary OB/GYN.
Our four-day coverage of this year’s American Diabetes Association’s 71st Scientific Sessions begins today and includes the results of major clinical trials and ongoing news
and information of interest to clinicians who treat type 1 and 2 diabetes.
|
|
New Research
Toenails clip myth: Mercury in fish is no heart hazard
Jane Smith, MD |
A study of stored toenail clippings reveals that mercury levels from eating fish pose no heart disease or stroke hazard. Measuring mercury levels in toenails is a good indicator of long-term exposure to mercury from eating fish, according to the investigators.» MORE
|
|
Insulin resistance improves with testosterone replacement
Applying a testosterone gel patch daily improves insulin resistance in hypogonadal men with type 2 diabetes and/or metabolic syndrome, found researchers from the United Kingdom.» MORE
|
|
Treatment Updates
TIA doubles risk of MI; highest risk is in those younger than 60
A transient ischemic attack (TIA) doubles the risk of myocardial infarction (MI), and this increase in risk persists for several years. Some 456 patients (Mean age: 71 years) who were identified from a medical records database (Rochester Epidemiology Project) as having been diagnosed with a TIA between 1985 and 1994 were followed for a median of 10.2 years. » MORE
|
|
Pioglitazone prevents diabetes in impaired glucose tolerance
James Jones, MD |
Pioglitazone taken prophylactically provided marked protection against the onset of type 2 diabetes in persons at high risk of the disease. In a double-blind study, 602 subjects with impaired glucose tolerance and a body mass index of 25 kg/m2 or greater were randomized to pioglitazone (30 mg/day for the first month, increased to 45 mg/day thereafter) or placebo.» MORE
|
|
Breaking News
OTC PPIs not likely to increase fracture risk, says FDA
Short-term use of over-the-counter (OTC) proton pump inhibitors (PPIs) probably does not pose an increased risk for hip, spine, and wrist fractures, according to the U.S. Food and Drug Administration (FDA). In May 2010, the FDA announced that PPI labeling would be revised to include a warning about a possible increased risk of fractures.» MORE
|
|
Resistant hypertension may be ‘white coat’ phenomenon
More than one third of patients thought to have resistant hypertension had white-coat hypertension during 24-hour ambulatory monitoring, according to research from the University of Barcelona in Spain.» MORE
|
|
Patient Care
Osteoarthritis linked to excess mortality
Patients with hip or knee osteoarthritis (OA) have a higher risk for death than the general population. In a population-based cohort study, Swiss investigators assessed all-cause and disease-specific mortality in 1,163 patients 35 years or older who had symptomatic, radiologically confirmed hip or knee OA.» MORE
|
|
Watch for bone loss in adolescents who undergo bariatric surgery
Adolescents who undergo bariatric surgery lose bone in the first 2 years after surgery. Investigators from Children’s Hospital Medical Center in Cincinnati did a retrospective chart review of 61 adolescents (mean age: 17.3 years) who underwent laparoscopic gastric bypass between 2001 and 2008 and had dual-energy radiographic absorptiometry scans before surgery (when possible) and then every 3 to 6 months for 2 years. Whole body bone mineral content (BMC) decreased by 5.2% at the end of 1 year and by 7.4% by 2 years following bariatric surgery.» MORE
|
Medical Economics is pleased to share this ADA conference coverage with the readers of:
 |
|
From the conference floor
Picture caption
|
Picture caption
|
|
Picture caption
|
Picture caption
|
|
DISCLAIMER:
This information has been independently developed and provided by the editors of Medical Economics. The sponsor does not endorse and is not responsible for the accuracy of the content or for practices or standards of non-sponsor sources.
|
|
|
Exhibit Hall Hours
Saturday, June 25
10 a.m. – 4 p.m.
Sunday, June 26
10 a.m. – 4 p.m.
Monday, June 27
10 a.m. – 2 p.m.
We welcome your feedback!
Please send your comments to:
Medical Economics editorial staff
medec@advanstar.com |
|
